Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.

The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.

Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.

Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.

Revenues were distributed as follows:

Regions, mSEK 25-Sep 24-Sep Change Q3 2025 Q3 2024 Change YTD 2025 YTD 2024 Change
The Nordics 26.5 25.4 4% 79.6 72.5 10% 235.1 214.0 10%
Central Europe 93.8 48.7 93% 242.8 138.6 75% 657.9 394.4 67%
East Europe 29.4 28.3 4% 89.7 88.3 2% 276.2 279.9 -1%
South & West Europe 50.1 38.0 32% 137.2 104.2 32% 399.2 264.5 51%
The Baltics 8.9 7.2 24% 28.6 21.9 31% 85.3 69.4 23%
North America 41.3 20.3 103% 129.8 52.6 147% 382.1 134.0 185%
Asia-Pacific 21.6 9.6 125% 63.7 22.3 186% 212.7 47.5 348%
Africa 1.9 1.2 58% 5.8 4.0 46% 16.0 10.9 47%
Zinzino 273.5 178.7 53% 777.3 504.4 54% 2264.5 1414.6 60%
Faun Pharma 3.7 5.8 -36% 9.4 28.4 -67% 40.4 79.7 -49%
Zinzino Group 277.2 184.5 50% 786.7 532.8 48% 2304.9 1494.3 54%


Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

<nav class="navigation posts-navigation" aria-label="Posts"> <h2 class="screen-reader-text">Posts navigation</h2> <div class="nav-links"><div class="nav-previous"><a href="https://www.businessforhome.org/author/liam/page/6/" >Older posts</a></div><div class="nav-next"><a href="https://www.businessforhome.org/author/liam/page/4/" >Newer posts</a></div></div> </nav>